Home - Products - Others - Other Targets - 3-O-Acetyl-20-Hydroxyecdysone

3-O-Acetyl-20-Hydroxyecdysone

CAS No. 22961-68-8

3-O-Acetyl-20-Hydroxyecdysone( —— )

Catalog No. M21779 CAS No. 22961-68-8

3-O-Acetyl-20-Hydroxyecdysone is an steroid isolated from the roots of Cyanotis arachnoidea C.B.Clark.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 302 Get Quote
10MG 447 Get Quote
25MG 714 Get Quote
50MG 1017 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    3-O-Acetyl-20-Hydroxyecdysone
  • Note
    Research use only, not for human use.
  • Brief Description
    3-O-Acetyl-20-Hydroxyecdysone is an steroid isolated from the roots of Cyanotis arachnoidea C.B.Clark.
  • Description
    3-O-Acetyl-20-Hydroxyecdysone is an steroid isolated from the roots of Cyanotis arachnoidea C.B.Clark.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    22961-68-8
  • Formula Weight
    522.67
  • Molecular Formula
    C??H??O?
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC(C)(O)CC[C@@H](O)[C@](C)(O)[C@H]1CCC2(O)C3=CC([C@@]4([H])C[C@H](OC(C)=O)[C@H](O)C[C@]4(C)[C@@]3([H])CC[C@]12C)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • 2-Methylglutaric aci...

    2-Methylglutaric acid is an organic acid normally found in human urine in healthy adults and children. 2-Methylglutaric acid is a metabolite of succinic acid a citric acid cycle intermediate.

  • Benzoylhypacoitine

    Benzoylhypacoitine might be the principal active components which affect mitochondrial growth by Fuzi and its processed products.

  • GSK-626616

    GSK-626616 is a potent and orally bioavailable DYRK3 inhibitor (IC50: 0.7 nM). It inhibits other members of the DYRK family with similar potency. GSK-626616 is a potential therapy for the treatment of anemia.